Biotech Company: Successfully migrating a legacy system to Veeva Vault RIM

Fallstudie herunterladen

Herausforderung

A biotechnology company with a focus on medications for patients with serious diseases wanted to migrate part of its portfolio to Veeva Vault’s RIM cloud solution. The challenge was moving from a legacy system to a highly organized platform, which required transforming the metadata to fit into Veeva Vault RIM. The migration involved two separate legacy systems – one containing clinical and regulatory documents and the other involving health authority correspondence, submissions, and registration data. Veeva also limits the daily API burst, which in return limits the number of documents that can be imported at one time.

Vorteile für den Kunden

  • Audit-compliant migration process
  • Excellent throughput during content migration
  • Precise and transparent migration control

Kunde

Global Biotech Company

Partner

  • Veeva

Technologie / Service

  • Documentum
  • Veeva Vault

Branche

  • Life Sciences

Topics

  • Cloud Migration
  • migration-center

Solution

fme with its product migration-center was chosen to partner with the client to do the migration. The capability of migration-center to scan different data sets helped to successfully migrate the two separate legacy systems to the Veeva Vault RIM target system. In addition, the tranformation function provided the ability to enrich the data prior to the import. Finally, the functionality to run multiple importers in parallel handled the limitation on the daily API burst successfully.

Technology

  • Product used: migration-center 3.9
  • Source system: OpenText Documentum, QUMAS
  • Target system: Veeva Vault RIM
Fallstudie | Biotech Company: Successfully migrating a legacy system to Veeva Vault RIM

Kontakt

Ich bin für Sie da
Haben Sie Fragen zu unserem Leistungsangebot oder wünschen Sie weitere Informationen? Setzen Sie sich gerne mit mir in Verbindung um zu erfahren, wie wir Sie unterstützen können.

Ich freue mich auf Ihre Anfrage!

fme AG